Aclaris Therapeutics, Inc. Insider Trading for December 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aclaris Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aclaris Therapeutics, Inc. for December 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 27 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.89 | 1 | 7 | 1 | |
| Dec 27 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.86 | 1 | 7 | 1 | |
| Dec 27 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.92 | 1 | 7 | 1 | |
| Dec 27 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.89 | 1 | 7 | 1 | |
| Dec 27 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.86 | 1 | 7 | 1 | |
| Dec 27 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.92 | 1 | 7 | 1 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.95 | 1 | 7 | 1 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.84 | 1 | 7 | 1 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Flynn James E | 10% Owner | Option Exercise | J | 6.91 | 1 | 7 | 1 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,250 | 0 | 1,250 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 6.30 | 356 | 2,243 | 162,409 | 162.8 K to 162.4 K (-0.22 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 1,250 | 0 | 162,765 | 161.5 K to 162.8 K (+0.77 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 2,925 | 0 | 2,925 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 6.30 | 833 | 5,248 | 910,124 | 911 K to 910.1 K (-0.09 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 2,925 | 0 | 910,957 | 908 K to 911 K (+0.32 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,450 | 0 | 1,450 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Payment of Exercise | F | 6.30 | 412 | 2,596 | 269,480 | 269.9 K to 269.5 K (-0.15 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Buy | M | 0.00 | 1,450 | 0 | 269,892 | 268.4 K to 269.9 K (+0.54 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,750 | 0 | 1,750 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Payment of Exercise | F | 6.30 | 498 | 3,137 | 8,015 | 8.5 K to 8 K (-5.85 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Buy | M | 0.00 | 1,750 | 0 | 8,513 | 6.8 K to 8.5 K (+25.88 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Option Exercise | M | 0.00 | 1,625 | 0 | 1,625 | |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Payment of Exercise | F | 6.30 | 446 | 2,810 | 139,443 | 139.9 K to 139.4 K (-0.32 %) |
| Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Buy | M | 0.00 | 1,625 | 0 | 139,889 | 138.3 K to 139.9 K (+1.18 %) |
| Dec 20 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 1,075 | 0 | 1,075 | |
| Dec 20 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 6.30 | 306 | 1,928 | 79,645 | 80 K to 79.6 K (-0.38 %) |
| Dec 20 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 1,075 | 0 | 79,951 | 78.9 K to 80 K (+1.36 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 3,033 | 0 | 6,067 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 3,033 | 0 | 6,067 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 7.31 | 863 | 6,309 | 908,032 | 908.9 K to 908 K (-0.09 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 7.31 | 863 | 6,309 | 908,032 | 908.9 K to 908 K (-0.09 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 3,033 | 0 | 908,895 | 905.9 K to 908.9 K (+0.33 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 3,033 | 0 | 908,895 | 905.9 K to 908.9 K (+0.33 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,300 | 0 | 2,600 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,300 | 0 | 2,600 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 7.31 | 370 | 2,705 | 161,515 | 161.9 K to 161.5 K (-0.23 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 7.31 | 370 | 2,705 | 161,515 | 161.9 K to 161.5 K (-0.23 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 1,300 | 0 | 161,885 | 160.6 K to 161.9 K (+0.81 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 1,300 | 0 | 161,885 | 160.6 K to 161.9 K (+0.81 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,300 | 0 | 2,600 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,300 | 0 | 2,600 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Payment of Exercise | F | 7.31 | 370 | 2,705 | 268,442 | 268.8 K to 268.4 K (-0.14 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Payment of Exercise | F | 7.31 | 370 | 2,705 | 268,442 | 268.8 K to 268.4 K (-0.14 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Buy | M | 0.00 | 1,300 | 0 | 268,812 | 267.5 K to 268.8 K (+0.49 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Buy | M | 0.00 | 1,300 | 0 | 268,812 | 267.5 K to 268.8 K (+0.49 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 1,733 | 0 | 3,467 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 1,733 | 0 | 3,467 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 7.31 | 493 | 3,604 | 78,876 | 79.4 K to 78.9 K (-0.62 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 7.31 | 493 | 3,604 | 78,876 | 79.4 K to 78.9 K (-0.62 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 1,733 | 0 | 79,369 | 77.6 K to 79.4 K (+2.23 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 1,733 | 0 | 79,369 | 77.6 K to 79.4 K (+2.23 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Option Exercise | M | 0.00 | 1,300 | 0 | 2,600 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Option Exercise | M | 0.00 | 1,300 | 0 | 2,600 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Payment of Exercise | F | 7.31 | 357 | 2,610 | 138,264 | 138.6 K to 138.3 K (-0.26 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Payment of Exercise | F | 7.31 | 357 | 2,610 | 138,264 | 138.6 K to 138.3 K (-0.26 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Buy | M | 0.00 | 1,300 | 0 | 138,621 | 137.3 K to 138.6 K (+0.95 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Buy | M | 0.00 | 1,300 | 0 | 138,621 | 137.3 K to 138.6 K (+0.95 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,013 | 0 | 2,025 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Payment of Exercise | F | 7.31 | 288 | 2,105 | 6,763 | 7.1 K to 6.8 K (-4.08 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,013 | 0 | 2,025 | |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Buy | M | 0.00 | 1,013 | 0 | 7,051 | 6 K to 7.1 K (+16.78 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Payment of Exercise | F | 7.31 | 288 | 2,105 | 6,763 | 7.1 K to 6.8 K (-4.08 %) |
| Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Buy | M | 0.00 | 1,013 | 0 | 7,051 | 6 K to 7.1 K (+16.78 %) |